<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Most Epstein-Barr virus (EBV)-positive Burkitt's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BLs</z:e>) carry a <z:mp ids='MP_0002169'>wild-type</z:mp> EBV genome and express EBV nuclear antigen 1 (EBNA1) selectively from the BamHI Q promoter (latency I) </plain></SENT>
<SENT sid="1" pm="."><plain>Recently we identified a distinct subset of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BLs</z:e> carrying both <z:mp ids='MP_0002169'>wild-type</z:mp> and EBNA2 gene-deleted (transformation-defective) <z:mp ids='MP_0001799'>viral</z:mp> genomes </plain></SENT>
<SENT sid="2" pm="."><plain>The cells displayed an atypical "BamHI W promoter (Wp)-restricted" form of latency where Wp (rather than Qp) was active and EBNA1, -3A, -3B, -3C, and -LP were expressed in the absence of EBNA2 or latent membrane proteins 1 and 2 </plain></SENT>
<SENT sid="3" pm="."><plain>Here we present data strongly supporting the view that the EBNA2-deleted genome is transcriptionally active in these cells and the <z:mp ids='MP_0002169'>wild-type</z:mp> genome is silent </plain></SENT>
<SENT sid="4" pm="."><plain>Single-cell cloning of three parental Wp-restricted <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> lines generated clones carrying either both <z:mp ids='MP_0001799'>viral</z:mp> genomes or the EBNA2-deleted genome only, never clones with the <z:mp ids='MP_0002169'>wild-type</z:mp> genome only </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> rescued clones displayed the Wp-restricted form of latency characteristic of the parent line and retained the original parent <z:mp ids='MP_0005384'>cell phenotype</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>Interestingly, Wp-restricted parent lines and derived clones were markedly more resistant to inducers of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> than standard latency I <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> lines </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, in vitro <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> of EBV-negative <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> lines with an EBNA2 gene-deleted virus generated EBV-positive converts with Wp-restricted latency and a similarly marked <z:mpath ids='MPATH_3'>apoptosis</z:mpath> resistance </plain></SENT>
<SENT sid="8" pm="."><plain>We postulate that, in the subset of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BLs</z:e> displaying Wp-restricted latency, <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> of a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> progenitor cell with an EBNA2 gene-deleted virus has provided that cell with a survival advantage through broadening antigen expression to include the EBNA3 proteins </plain></SENT>
</text></document>